Filana Therapeutics, Inc. Marketable Securities (Current)
Filana Therapeutics, Inc. (FLNA) had Marketable Securities (Current) of $2.10 million as of 2016-12-31, per its 10-K filed 2018-02-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2018-02-06
- 2016-12-31: Marketable Securities, Current $2.10M.
- 2016-09-30: Marketable Securities, Current $550.00K.
- 2016-03-31: Marketable Securities, Current $1.50M.
- 2015-09-30: Marketable Securities, Current $900.00K.
| Period end | Marketable Securities, Current |
|---|---|
| 2016-12-31 | $2.10M 10-K · filed 2018-02-06 |
| 2016-09-30 | $550.00K 10-Q · filed 2016-10-26 |
| 2016-03-31 | $1.50M 10-Q · filed 2016-05-05 |
| 2015-09-30 | $900.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $950.00K 10-Q · filed 2015-07-23 |
| 2015-03-31 | $2.00M 10-Q · filed 2015-05-08 |
| 2014-09-30 | $1.10M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $250.00K 10-Q · filed 2014-08-06 |
| 2014-03-31 | $1.25M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $1.25M 10-K · filed 2015-02-18 |
| 2013-09-30 | $1.30M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $1.30M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $2.80M 10-Q · filed 2013-04-24 |
| 2012-12-31 | $6.90M 10-K · filed 2014-02-05 |
| 2012-09-30 | $4.29M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $14.92M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $22.12M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $24.99M 10-K · filed 2013-02-08 |
| 2011-09-30 | $27.65M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $38.21M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $86.43M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |